The clinical significance of stringent complete response in multiple myeloma is surpassed by minimal residual disease measurements.

by Maria-Teresa Cedena, Estela Martin-Clavero, Sandy Wong, Nina Shah, Natasha Bahri, Rafael Alonso, Carmen Barcenas, Antonio Valeri, Johny Salazar Tabares, Jose Sanchez-Pina, Clara Cuellar, Thomas Martin, Jeffrey Wolf, Juan-Jose Lahuerta, Joaquin Martinez-Lopez
Published 2020-01-01

NKG2D-CAR-transduced natural killer cells efficiently target multiple myeloma

by Alejandra Leivas, Antonio Valeri, Laura Córdoba, Almudena García-Ortiz, Alejandra Ortiz, Laura Sánchez-Vega, Osvaldo Graña-Castro, Lucía Fernández, Gonzalo Carreño-Tarragona, Manuel Pérez, Diego Megías, María Liz Paciello, Jose Sánchez-Pina, Antonio Pérez-Martínez, Dean A. Lee, Daniel J. Powell, Paula Río, Joaquín Martínez-López
Published 2021-08-01

Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant

by Rebeca Bailén, Rebeca Bailén, José Luis Vicario, Laura Solán, Irene Sánchez-Vadillo, Pilar Herrera, María Calbacho, Raquel Alenda, José Luis López-Lorenzo, Karem Humala, Anabelle Chinea, José Sánchez-Pina, Antonio Balas, Miguel Ángel Moreno, Javier Arzuaga, Virginia Pradillo, Nieves Dorado, Nieves Dorado, Gillen Oarbeascoa, Gillen Oarbeascoa, Javier Anguita, Javier Anguita, Javier Anguita, José Luis Díez-Martín, José Luis Díez-Martín, José Luis Díez-Martín, Mi Kwon, Mi Kwon
Published 2021-05-01